EDGAR Filing Documents for 0001129928-23-000052

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001129928-23-000052

Filing Date

2023-09-19

Accepted

2023-09-19 17:28:10

Documents

Period of Report

2023-09-19

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	form6kcantorhcconf2023.htm	6-K	18212
2	EX-99.1	cantorconference.htm	EX-99.1	9811
	Complete submission text file	0001129928-23-000052.txt		28970

Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5

Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380

ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 231264784
SIC: 2834 Pharmaceutical Preparations